Literature DB >> 1587530

Polymerase chain reaction amplification of two polymorphic simple repeat sequences within the von Willebrand factor gene: application to family studies in von Willebrand disease.

A M Cumming1, J G Armstrong, K Pendry, A M Burn, R T Wensley.   

Abstract

We have used the polymerase chain reaction to amplify two variable number of tandem repeats (VNTRs) within a region of repetitive DNA located in intron 40 of the von Willebrand factor (vWf) gene. Heterozygosity for VNTR I was observed in 30 out of 39 normal unrelated individuals tested (77%), and for VNTR II in 29 out of 44 (66%) similar individuals. Family studies were carried out on 11 kindreds with von Willebrand disease (vWD). Ten of these families were found to be informative for one or other of the VNTRs or for a combination of data from both VNTRs. This method can be used for antenatal diagnosis and for carrier diagnosis in recessive forms of vWD. It is also useful for tracking the gene associated with vWD in type I families where there may be one or more individuals with a phenotypically uncertain diagnosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587530     DOI: 10.1007/bf00217122

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Letter: A method for assaying von Willebrand factor (ristocetin cofactor).

Authors:  D E Macfarlane; J Stibbe; E P Kirby; M B Zucker; R A Grant; J McPherson
Journal:  Thromb Diath Haemorrh       Date:  1975-09-30

2.  A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma.

Authors:  R M HARDISTY; J C MACPHERSON
Journal:  Thromb Diath Haemorrh       Date:  1962-05-15

3.  Gene deletions correlate with the development of alloantibodies in von Willebrand disease.

Authors:  B B Shelton-Inloes; F F Chehab; P M Mannucci; A B Federici; J E Sadler
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

Review 4.  von Willebrand factor and von Willebrand disease.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

5.  Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

Authors:  D Ginsburg; R I Handin; D T Bonthron; T A Donlon; G A Bruns; S A Latt; S H Orkin
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

6.  Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method.

Authors:  D C Lynch; T S Zimmerman; C J Collins; M Brown; M J Morin; E H Ling; D M Livingston
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

7.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

8.  von Willebrand disease investigated by two novel RFLPs.

Authors:  F Bernardi; S Guerra; P Patracchini; S Volinia; D Buzzoni; G Ballerini; A Casonato; G Marchetti
Journal:  Br J Haematol       Date:  1988-02       Impact factor: 6.998

9.  Rapid assessment of haemophilia A carrier state by non-invasive techniques using the polymerase chain reaction.

Authors:  J Ball; L J Warnock; F E Preston
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

10.  Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene.

Authors:  I R Peake; D Bowen; P Bignell; M B Liddell; J E Sadler; G Standen; A L Bloom
Journal:  Blood       Date:  1990-08-01       Impact factor: 22.113

View more
  2 in total

1.  An unexpected transmission of von Willebrand disease type 3: the first case of maternal uniparental disomy 12.

Authors:  Pierre Boisseau; Mathilde Giraud; Catherine Ternisien; Agnès Veyradier; Edith Fressinaud; Armelle Lefrancois; Stéphane Bezieau; Marc Fouassier
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

2.  Copy number variation analysis by ligation-dependent PCR based on magnetic nanoparticles and chemiluminescence.

Authors:  Ming Liu; Ping Hu; Gen Zhang; Yu Zeng; Haowen Yang; Jing Fan; Lian Jin; Hongna Liu; Yan Deng; Song Li; Xin Zeng; Sauli Elingarami; Nongyue He
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.